Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Kartoon Studios, Inc.Kartoon Studios Reports 26% Revenue Decline but Improves Net Loss in Fiscal Year 2024
Loar Holdings Inc.Loar Holdings Inc. Reports 26.9% Revenue Growth to $402.8 Million in 2024
Cartica Acquisition CorpCartica Acquisition Corp Reports $10.97 Million Net Loss and Management Changes in 10-K Filing
Polar Power, Inc.Polar Power Reports $4.7 Million Net Loss for Fiscal Year 2024, Sales Decline by 9%
ENDRA Life Sciences Inc.ENDRA Life Sciences Reports $11.5 Million Net Loss for Fiscal Year 2024
Intellicheck, Inc.Intellicheck Reports 6% Revenue Growth to $19.997 Million for Fiscal Year 2024
Vivani Medical, Inc.Vivani Medical Reports $23.5 Million Net Loss for Fiscal Year 2024, Focuses on Clinical Development
QT IMAGING HOLDINGS, INC.QT Imaging Holdings Reports $8.98 Million Net Loss and $4.88 Million Revenue for 2024
GIFTIFY, INC.Giftify Reports $88.9 Million in Net Sales, Faces $18.8 Million Net Loss in 2024
HeartCore Enterprises, Inc.HeartCore Enterprises Reports 39.2% Revenue Growth to $30.4 Million for Fiscal Year 2024
Cocrystal Pharma, Inc.Cocrystal Pharma Reports $17.5 Million Net Loss and Declining Cash Position for Fiscal Year 2024
KULR Technology Group, Inc.KULR Technology Group Reports Record $10.7 Million Annual Revenue, Expands Bitcoin Holdings
FTC Solar, Inc.FTC Solar Reports 62.7% Revenue Decline and Restructuring Efforts for Fiscal Year 2024
Marker Therapeutics, Inc.Marker Therapeutics Reports $6.6M Revenue Growth and Improved Net Loss in 2024
FARADAY FUTURE INTELLIGENT ELECTRIC INC.Faraday Future Reports $355.8M Net Loss for 2024, Revenue Declines to $539,000
Monopar TherapeuticsMonopar Therapeutics Reports Increased Net Loss and Significant Liquidity Growth in 2024
KALA BIO, Inc.Kala Bio Reports $38.5 Million Net Loss for 2024, Highlights KPI-012 Development Progress
Bubblr Inc.Bubblr Inc. Reports 104% Revenue Growth but Continues to Operate at a Loss in 2024
GALECTIN THERAPEUTICS INCGalectin Therapeutics Reports $47.2 Million Net Loss for Fiscal Year 2024
PALVELLA THERAPEUTICS, INC.Palvella Therapeutics Reports $17.4 Million Net Loss for 2024 Following Business Combination
BRAINSTORM CELL THERAPEUTICS INC.Brainstorm Cell Therapeutics Reports $11.6 Million Net Loss for 2024, Focuses on NurOwn® ALS Trial
Vulcan Infrastructure & Power Inc.Greenidge Generation Reports $59.5M Revenue Decline, Operating Loss Improvement in 2024
Braze, Inc.Braze Reports 25.8% Revenue Growth to $593.4 Million, Acquires OfferFit for $325 Million
Rapid Line Inc.Rapid Line Inc. Reports No Revenue and Net Loss Improvement for Fiscal Year Ending January 31, 2025
Venus Concept Inc.Venus Concept Reports 15.1% Revenue Decline and $47M Net Loss for Fiscal Year 2024